ArticleTherapeutic advances in drug safety2025

Real-world pharmacovigilance study on neonatal congenital anomalies associated with maternal drug exposure using the FDA Adverse Event Reporting System.

Jingping Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.